Atlas Trials

To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

Clinical trial NCT06216041 · RECRUITING

Trial details

NCT number
NCT06216041
Sponsor
Changchun Intellicrown Pharmaceutical Co. LTD
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Nonalcoholic Steatohepatitis (NASH)
Start date
2023-12-06
Primary completion
2025-06-01
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.